Fintel reports that on January 27, 2025, Morgan Stanley downgraded their outlook for Intellia Therapeutics (NasdaqGM:NTLA) ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

NAD, a vital molecule for cellular energy and DNA repair, plays a central role in aging and diseases like cancer and ...

CRISPR-Cas systems have been exploited for targeted genome editing. Applying the CRISPR-Cas9 system to edit high GC content genomes has been challenging due to its high off-target activity.

New study reveals that TLE6 protein deficiency causes male infertility in mice. These findings suggest potential genetic ...

In a Phase I/II trial, patients with X-linked chronic granulomatous disease will receive a treatment created using a new ...

Colossal Biosciences is now valued at over $10 billion and is working on ambitious projects to resurrect multiple long ...

Colossal Biosciences is working to bring back species like the woolly mammoth using CRISPR-Cas9 technology. The project aims to restore lost biodivers ...

Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.

Bring your slides in person or send them via mail. See mail address below. All projects must be agreed with FinGEEC staff by email before delivering the slides. Fluorescent slides are stored in +4 ºC.

Innovative synthetic biology techniques are revolutionizing microbiota-based therapies, enhancing microbial functions for ...